Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Drug-coated Balloon Angioplasty in Sri Lanka
Author(s): Yanushka Herath , Judy Ranaweera , Thisal Semina , et al Added: 2 weeks ago

Intervention

Prevention & Chronic Conditions
TCT 25: VICTORY Trial: Intravascular Lithotripsy vs Super-High-Pressure Balloons for Calcified Coronary Lesions
Author(s): Matthias Bossard Added: 1 month ago
TCT 2025 - The randomized VICTORY Study finds OCT-guided PCI involving lesion preparation with the OPN super-high-pressure non-compliant balloon is non-inferior to intravascular lithotropsy.Dr Matthias Bossard (Kantonsspital Lucerne, Lucerne, CH) joins us to discuss findings from the VICTORY Trial, a randomized, multicenter, non-inferiority comparison evaluating intravascular lithotripsy versus… View more

Intervention

MI/ACS
TCT 2025: Short-CUT: Lithotripsy Vs Cutting Balloon for CAD
Author(s): Suzanne J Baron Added: 1 month ago
TCT 2025 — Dr Suzanne J Baron (Massachusetts General Hospital, US), principal investigator of the Short-CUT trial (NCT06089135; Baim Institute for Clinical Research), joins us to discuss this investigator-initiated, multicentre randomized controlled study.The trial enrolled 410 patients with moderate to severe coronary artery calcification across up to 22 international sites. Eligible… View more

Intervention
CRT 25: 2Y Outcomes of Prevail Paclitaxel-Coated Balloon VS Contemporary DCB
Author(s): Sacharias Von Koch Added: 9 months ago
CRT 25 - Two-year outcomes of the Prevail paclitaxel-coated balloon show no difference in clinical outcomes compared to other drug-coated balloons (DCBs), suggesting the Prevail DCB is as effective and safe as other contemporary DCB's in a real-world setting. The Prevail DCB was also associated with lower rates of myocardial infarction in the sub-group analysis of patients who also underwent… View more

Intervention
Balloon Techniques for Coronary Calcification Lesions
Author(s): Max W Maffey , Rodrigo Bagur Added: 1 year ago

Imaging & Diagnostics

Intervention
SMART Trial
Author(s): Didier Tchétché Added: 1 year ago
Dr Didier Tchétché (Clinique Pasteur, Toulouse, FR) joins us to discuss findings from the SMART Trial.This prospective, multi-centre, randomised controlled study aims to investigate the valve safety and performance of self expanding as compared to balloon-expandable transcatheter aortic valve implantation (TAVI) in patients with small aortic annuli and severe symptomatic aortic stenosis. At… View more

Intervention
TCT 2025: SELUTION DeNovo: 1-Year Results Comparing Sirolimus Balloon vs DES in PCI
Author(s): Christian Spaulding Added: 1 month ago
TCT 2025 — Prof Christian M Spaulding (European Hospital Georges Pompidou & INSERM U 970, FR), principal investigator of the SELUTION DeNovo trial (M.A. Med Alliance S.A.; NCT04859985), joins us to share the one year results.This international, multicentre randomised trial enrolled over 3,300 patients at 50 sites across Europe and Asia to compare a sirolimus-eluting balloon (SEB) plus provisional… View more

Intervention
CIRSE 25: The BIONETIC-I Study
Author(s): Marianne Brodmann Added: 2 months ago
CIRSE Congress 2025 - 24-month results show the Biotronik Dynetic-35 cobalt chromium balloon-expandable stent was safe and effective in iliac arteries.Prof Marianne Brodmann (Medical University of Graz, Graz, AT) joins us to discuss 24-month findings from BIONETIC-I (NCT04830228). The prospective, international, multi-center, single-arm study aimed to investigate the safety and effectiveness of… View more

Intervention

Vascular Disease and Surgery
TCT 24: Sirolimus- vs. Paclitaxel-Coated Balloon Angioplasty
Author(s): Ulf Teichgräber Added: 1 year ago
TCT Conference 2024 - Safety and efficacy outcomes of the trial shows that percutaneous transluminal angioplasty (PTA) with the sirolimus drug coated balloon (DCB) in patients with femoropopliteal artery disease was/was not noninferior to PTA with the paclitaxel DCB.Prof Ulf Teichgräber joins us onsite at TCT Conference to discuss the findings from the sirolimus- vs. paclitaxel-coated balloon… View more

Intervention

Vascular Disease and Surgery
TCT 24: The ECLIPSE Trial
Author(s): Ajay J Kirtane Added: 1 year ago
TCT Conference 2024 - Routine use of orbital atherectomy system (OAS) did not improve minimal stent area (MSA) or target vessel failure (TVF) at one year compaared to conventional balloon angioplasty.Dr Ajay J Kirtane (Columbia University Medical Center and New York-Presbyterian Hospital, New York, US) joins us onsite at TCT Conference to discuss the findings from ECLIPSE (NCT03108456; Abbott… View more

Intervention